tirzepatide surpass-4 SURPASS-4: slows kidney disease in adults with type 2 diabetes, CV risk Hush Medical Spa
Description
Here is the framework

Clinical studies have shown that Zepbound may lead to greater average weight loss compared to semaglutide GLP-1

Lixisenatide (Adlyxin)

Lyndsey made me feel comfortable from start to finish and took her time explaining everything and making sure the results fit my face

Pros: The lowest flat-rate price in this roundup, at $149 per month Flat pricing through the 15 mg dose, with FSA and HSA accepted LegitScript certified, with a large and currently positive review base Cons: The $149 rate requires annual prepayment, not month-to-month billing The partner pharmacy is not named, and no PCAB or ACHC badges are shown The recent review surge is PR-driven, and there is no bundled coaching Quick comparison vs Mochi: CoreAge RX is cheaper than Mochi at 15 mg maintenance, and the savings are real

Tirzepatide vs Semaglutide: Side Effects and Tolerability Comparison Common Side Effects for Both Medications The side effect profiles are remarkably similar between the two medications, with gastrointestinal effects being most common: Most Frequent (affecting 10-40% of users): Nausea (typically worst in first 4-8 weeks) Diarrhea or constipation Vomiting (less common than nausea) Abdominal pain or discomfort Decreased appetite (desired effect for weight loss) Less Common (affecting 5-10% of users): Fatigue or tiredness Headache Dizziness Acid reflux or heartburn Burping or gas Management Strategies: Start with lowest dose and increase gradually Eat smaller, more frequent meals Avoid fatty or spicy foods initially Stay well hydrated Take medication at consistent times Serious But Rare Side Effects Both medications carry similar warnings for: Pancreatitis : Severe abdominal pain requiring immediate medical attention Gallbladder problems : May require surgical intervention in some cases Kidney injury : Particularly if severe dehydration occurs Thyroid C-cell tumors : Based on animal studies, human risk unclear Severe allergic reactions : Rare but requires immediate medical care Diabetic retinopathy complications : In patients with existing eye disease Practical Considerations for Patients Dosing and Administration Tirzepatide dosing schedule: Start: 2.5mg weekly for 4 weeks (initiation dose) Increase: 5mg weekly for 4 weeks Further increases: Can go to 10mg then 15mg based on response and tolerability Maintenance: Most patients maintain on 10-15mg weekly Semaglutide dosing schedule: Start: 0.25mg weekly for 4 weeks (Wegovy) or 0.5mg (Ozempic) Gradual increases every 4 weeks Maximum: 2.4mg weekly for weight loss, 2.0mg for diabetes Cost and Insurance Considerations Cost remains a significant factor for many patients
